Tilray Brands Inc.
1.18
0.00 (0.00%)
At close: Jan 14, 2025, 3:59 PM
undefined%
Bid 1.17
Market Cap 1.11B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.3
PE Ratio (ttm) -3.93
Forward PE n/a
Analyst Hold
Ask 1.18
Volume 36,200,152
Avg. Volume (20D) 32,525,963
Open 1.18
Previous Close 1.18
Day's Range 1.15 - 1.19
52-Week Range 1.14 - 2.97
Beta undefined

About TLRY

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils,...

Sector Healthcare
IPO Date Jul 19, 2018
Employees 2,650
Stock Exchange NASDAQ
Ticker Symbol TLRY

Analyst Forecast

According to 3 analyst ratings, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is $1.88, which is an increase of 59.32% from the latest price.

Buy 0.00%
Hold 100.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Tilray Brands Inc. is scheduled to release its earnings on Apr 8, 2025, before market opens.
Analysts project revenue of $220.52M, reflecting a 17.09% YoY growth and earnings per share of -0.04.
4 days ago · Source
-10.22%
Tilray Brands shares are trading lower after the c... Unlock content with Pro Subscription
2 months ago · Source
+5%
Shares of cannabis-linked stocks are trading higher after Chris Christie in a Benzinga exclusive suggested he thinks Trump may attempt to change illegal status of marijuana via the DEA.